Ingestion of Cannabis oil in Fibromyalgic people

Not Applicable

• Conditions: Fibromyalgia; M79.7

• Registration Number: RBR-2f8mtn
• Lead Sponsor: Escola de Saúde Pública de Florianópolis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-03-17
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Data analysis completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Fibromyalgia diagnosis (ACR 2010 criteria); age over 18 years; ability to sign the informed consent form; presence of moderate to severe symptoms despite therapies in use; at least one medical or nursing consultation at Health Center on the last year.

Exclusion Criteria

Decompensated organic comorbidities and/or risk psychiatric conditions (schizophrenia, psychosis, severe personality disorder, current suicidal ideation); other well defined cause of chronic pain; current pregnancy/lactation; moderate or severe cognitive impairment; history of cannabinoids sensitivity.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Significant improvement in symptoms and quality of life of patients in the Intervention Group, comparing the pre-intervention and post-intervention moments, assessed with the Fibromyalgia Impact Questionnaire

Secondary Outcome Measures

Name	Time	Method
ão são esperados desfechos secundários